Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
Titel:
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
Auteur:
Distler, Oliver Allanore, Yannick Denton, Christopher P Kuwana, Masataka Matucci-Cerinic, Marco Pope, Janet E Atsumi, Tatsuya Bečvář, Radim Czirják, László Hachulla, Eric Ishii, Tomonori Ishikawa, Osamu Johnson, Sindhu R De Langhe, Ellen Stagnaro, Chiara Riccieri, Valeria Schiopu, Elena Silver, Richard M Smith, Vanessa Steen, Virginia Stevens, Wendy Szücs, Gabriella Truchetet, Marie-Elise Wosnitza, Melanie Laapas, Kaisa Kramer, Frank Khanna, Dinesh